Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.

Goulet CR, Champagne A, Bernard G, Vandal D, Chabaud S, Pouliot F, Bolduc S.

BMC Cancer. 2019 Feb 11;19(1):137. doi: 10.1186/s12885-019-5353-6.

2.

Modeling human bladder cancer.

Ringuette-Goulet C, Bolduc S, Pouliot F.

World J Urol. 2018 Nov;36(11):1759-1766. doi: 10.1007/s00345-018-2369-5. Epub 2018 Jun 14. Review.

PMID:
29948049
3.

Engineering Tissues without the Use of a Synthetic Scaffold: A Twenty-Year History of the Self-Assembly Method.

Saba I, Jakubowska W, Bolduc S, Chabaud S.

Biomed Res Int. 2018 Mar 8;2018:5684679. doi: 10.1155/2018/5684679. eCollection 2018. Review.

4.

Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling.

Ringuette Goulet C, Bernard G, Tremblay S, Chabaud S, Bolduc S, Pouliot F.

Mol Cancer Res. 2018 Jul;16(7):1196-1204. doi: 10.1158/1541-7786.MCR-17-0784. Epub 2018 Apr 10.

PMID:
29636362
5.

Adherence to antimuscarinics in children with overactive bladder.

Fortin A, Morin V, Ramsay S, Gervais P, Bolduc S.

Paediatr Child Health. 2017 Aug;22(5):255-258. doi: 10.1093/pch/pxx055. Epub 2017 May 17.

6.

Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery.

Ringuette Goulet C, Bernard G, Chabaud S, Couture A, Langlois A, Neveu B, Pouliot F, Bolduc S.

Biomaterials. 2017 Nov;145:233-241. doi: 10.1016/j.biomaterials.2017.08.041. Epub 2017 Aug 29.

PMID:
28888113
7.

Dimercaptosuccinic acid scintigraphy vs. ultrasound for renal parenchymal defects in children.

Marceau-Grimard M, Marion A, Côté C, Bolduc S, Dumont M, Moore K.

Can Urol Assoc J. 2017 Aug;11(8):260-264. doi: 10.5489/cuaj.4257.

8.

Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder.

Newgreen D, Bosman B, Hollestein-Havelaar A, Dahler E, Besuyen R, Snijder R, Sawyer W, Rittig S, Bolduc S.

J Urol. 2017 Oct;198(4):928-936. doi: 10.1016/j.juro.2017.05.038. Epub 2017 May 12.

PMID:
28506854
9.

Overactive bladder in children.

Ramsay S, Bolduc S.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2Suppl1):S74-S79. doi: 10.5489/cuaj.4337. Review.

10.

Vesicoureteral reflux: From prophylaxis to surgery.

Blais AS, Bolduc S, Moore K.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2Suppl1):S13-S18. doi: 10.5489/cuaj.4342. Review.

11.

Urothelial cell expansion and differentiation are improved by exposure to hypoxia.

Chabaud S, Saba I, Baratange C, Boiroux B, Leclerc M, Rousseau A, Bouhout S, Bolduc S.

J Tissue Eng Regen Med. 2017 Nov;11(11):3090-3099. doi: 10.1002/term.2212. Epub 2017 Feb 3.

PMID:
28156053
12.

Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study.

Morin F, Blais AS, Nadeau G, Moore K, Genois L, Bolduc S.

J Urol. 2017 Apr;197(4):1158-1163. doi: 10.1016/j.juro.2016.11.101. Epub 2016 Nov 30.

PMID:
27914999
13.

Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial.

Newgreen D, Bosman B, Hollestein-Havelaar A, Dahler E, Besuyen R, Sawyer W, Bolduc S, Rittig S.

Eur Urol. 2017 Mar;71(3):483-490. doi: 10.1016/j.eururo.2016.08.061. Epub 2016 Sep 28.

PMID:
27687820
14.

Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long-Term Results and Safety.

Ramsay S, Blais AS, Morin F, Moore K, Cloutier J, Bolduc S.

J Urol. 2017 Mar;197(3 Pt 2):963-967. doi: 10.1016/j.juro.2016.08.093. Epub 2016 Aug 26.

PMID:
27575606
15.

Novel three-dimensional autologous tissue-engineered vaginal tissues using the self-assembly technique.

Orabi H, Saba I, Rousseau A, Bolduc S.

Transl Res. 2017 Feb;180:22-36. doi: 10.1016/j.trsl.2016.07.019. Epub 2016 Aug 1.

PMID:
27543901
16.

Origin of Serum Affects Quality of Engineered Tissues Produced by the Self-Assembly Approach.

Chabaud S, Simard M, Gendreau I, Pouliot R, Bolduc S.

Scientifica (Cairo). 2016;2016:3825645. doi: 10.1155/2016/3825645. Epub 2016 May 16.

17.

Anticholinergic use in children: Persistence and patterns of therapy.

Blais AS, Bergeron M, Nadeau G, Ramsay S, Bolduc S.

Can Urol Assoc J. 2016 Mar-Apr;10(3-4):137-40. doi: 10.5489/cuaj.3527.

18.

Clinical challenges in tissue-engineered urethral reconstruction.

Ramsay S, Ringuette-Goulet C, Langlois A, Bolduc S.

Transl Androl Urol. 2016 Apr;5(2):267-70. doi: 10.21037/tau.2016.01.11. No abstract available.

19.

Production of a Self-Aligned Scaffold, Free of Exogenous Material, from Dermal Fibroblasts Using the Self-Assembly Technique.

Chabaud S, Bolduc S.

Dermatol Res Pract. 2016;2016:5397319. doi: 10.1155/2016/5397319. Epub 2016 Mar 9.

20.

Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder.

Blais AS, Nadeau G, Moore K, Genois L, Bolduc S.

Eur Urol. 2016 Jul;70(1):9-13. doi: 10.1016/j.eururo.2016.02.007. Epub 2016 Feb 11.

PMID:
26876327

Supplemental Content

Loading ...
Support Center